1/19
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Definition
a group of malignant neoplasms originating from hematopoietic stem cells. It is primarily characterized by:
Diffuse replacement of the bone marrow by unregulated, proliferating, immature neoplastic (blast) cells.
Disruption of normal hematopoiesis, leading to anemia, thrombocytopenia, and neutropenia.
hemopoietic stem cells
Hemopoietic stem cells are the origin of all blood cells
HSCs —> immature blast cell —> mature specialised cell
how do the malignant neoplasms form?
the HSCs —> immature blast cell that can’t mature (mutation)
called leukemic blast cells
stops the process of becoming specialised
Also has another mutation, uncontrolled cell division
they replicate lots
the HSCs should make more healthy Immature B/Cs
However, not enough space, nutrients and GFs in the bone marrow
The uncontrolled ones are taking them all
Bone marrow gets taken over by the leukemic blast cells
⇓ in RBCs, platelets and WBCs
Etiology of leukemia
Environmental
genetic abnormalities
therapy-related
genetic predisposition
Environmental and chemical exposures:
Ionising radiation (e.g. atomic bomb survivors, radiation therapy).
causes DNA damage in HSCs in the bone marrow
RESULTS IN :
Double-stranded DNA to breakpoint mutations
activates oncogenes
or inactivates tumour suppressor genes
= malignant transformation
Exposure to benzene, certain drugs, industrial toxins, chemicals, and gases.
Genetic abnormalities:
Chromosomal translocations and mutations such as:
Philadelphia chromosome (t(9;22)), commonly associated with Chronic Myelogenous Leukaemia (CML).
Gene mutations that disrupt normal cell cycle control and differentiation.
Therapy-related leukaemia:
May occur as a secondary malignancy following chemotherapy or radiotherapy, especially in Hodgkin's lymphoma.
Genetic predisposition:
Increased incidence seen in congenital disorders such as:
Down syndrome
Fanconi anemia
Bloom syndrome